DBVT 股價走勢圖
DBVT 股票價格預測
DBV Technologies S.A.
$19.65
-0.95%
$-0.19
收盤價：May 15, 16:00:00 GMT-4
$19.84
0.96%
$0.19
盤後：May 15, 20:00:00 GMT-4
返回
DBV Technologies S.A. (DBVT) 股票價格預測
關鍵數據
前收市價
$19.84
開盤價
$19.66
當日範圍
$19.44 - $19.91
52週區間
$7.52 - $26.18
交易量
66.9K
平均成交量
230.1K
股息收益率
--
每股盈餘 (TTM)
-4.50
市值
$1.1B
什麼是 DBV Technologies S.A.？
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Chatillon, Auvergne-Rhone-Alpes and currently employs 125 full-time employees. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.
